Rabbit Polyclonal HMGA1 Antibody

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human colon cancer tissue using P04027(HMGA1  Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using P04027(HMGA1  Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

**Background of HMGA1 Antibody**

HMGA1 (High Mobility Group A1) is a non-histone chromatin-associated protein involved in regulating gene expression by modulating DNA structure and facilitating transcriptional complexes. It plays a critical role in cellular processes like proliferation, differentiation, and apoptosis. Dysregulation of HMGA1 is linked to various cancers, where its overexpression correlates with tumor progression, metastasis, and poor prognosis. It also associates with metabolic disorders, such as diabetes, and developmental abnormalities.

HMGA1 antibodies are essential tools for studying its expression, localization, and function in both normal and pathological contexts. These antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), and chromatin immunoprecipitation (ChIP) to detect HMGA1 in tissue samples or cell lines. Researchers employ them to explore HMGA1's role in oncogenesis, epithelial-mesenchymal transition (EMT), and therapeutic resistance. Validating antibody specificity is crucial due to HMGA1's structural similarities with HMGA2 and potential post-translational modifications.

Understanding HMGA1 dynamics through these antibodies aids in identifying biomarkers for cancer diagnosis and assessing its potential as a therapeutic target. Ongoing research focuses on clarifying HMGA1's mechanisms in disease and leveraging antibodies for diagnostic or functional studies.